Loading publications…
The last 5 uploaded publications
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Riccardo Lencioni, Robert Montal, Ferrán Torres, Joong‐Won Park, Thomas Decaens, Jean‐Luc Raoul, Masatoshi Kudo, Charissa Chang, José Ríos, Valérie Boige, Éric Assenat, Yoon‐Koo Kang, Ho-Yeong Lim, Ian Walters, Josep M. Llovet (2017). Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. Journal of Hepatology, 66(6), pp. 1166-1172, DOI: 10.1016/j.jhep.2017.01.012.
Article145 days agoObjective response by mRECIST to predict survival in hepatocellular carcinoma: A multivariate, time-dependent analysis from the phase III BRISK-PS study.
Josep M. Llovet, Joong‐Won Park, Ferrán Torres, Thomas Decaens, Éveline Boucher, Jean‐Luc Raoul, Masatoshi Kudo, Charissa Chang, Valérie Boige, Éric Assenat, Yoon‐Koo Kang, Ho-Yeong Lim, Ian Walters, Riccardo Lencioni (2015). Objective response by mRECIST to predict survival in hepatocellular carcinoma: A multivariate, time-dependent analysis from the phase III BRISK-PS study.. Journal of Clinical Oncology, 33(15_suppl), pp. 4084-4084, DOI: 10.1200/jco.2015.33.15_suppl.4084.
Article145 days ago